The absence of cerebellar granule cell necrosis in the mouse following L-2-chloropropionic acid administration

Oral administration of L-2-chloropropionic acid (L-CPA) to rats either as a single dose (750 mg/kg) or daily doses (250 mg/kg per day for 3 days) prod uces selective necrosis to the granule cell layer of the cerebellum. As par t of a study to understand the mechanism of this selective toxicity, we inv estigated the toxicity of L-CPA and a related analogue, DL-2-bromopropionic acid to the mouse with particular emphasis on the brain. Following a singl e oral dose (up to 1000 mg/kg), or daily oral doses of 250 mg/kg per day L- CPA up to maximum tolerated doses, produced no evidence of neurotoxicity. S imilarly, daily oral doses of DL-2-bromopropionic acid at 250 mg/kg per day produced no evidence of neurotoxicity. The basis for the lack of response was explored by examining the metabolism and disposition of L-[2-C-14]-CPA in the mouse. Following a single oral dose of 250 mg/kg L-CPA, radioactivit y was rapidly absorbed from the gastrointestinal tract into the blood strea m. Peak plasma concentrations of radiolabel and L-CPA occurred within 2 h o f dosing at about 1.8 mM, and were then lost from the plasma with a half-li fe of 1 h. The only metabolite detected in the plasma was 2-S-cysteinylprop anoic acid derived from the glutathione conjugate. About 39% of the dose wa s excreted in the urine in the first 24 h, mainly as 2-S-cysteinylpropanoic acid with only a small amount of unchanged L-CPA. The remaining radiolabel from L-CPA was excreted in the faeces (26%) and exhaled as carbon dioxide (about 14%) over 72 h. Radiolabel from L-[2-C-14]-CPA was present ill the c erebellum at a peak concentration of 1 mM 1-2 h after dosing and then was l ost more slowly than from the plasma. Measurement of non-protein sulphydryl content in the brain, liver and kidneys showed a decrease in the liver and kidneys 4 h after dosing which recovered fairly rapidly, while a more prol onged decrease was found in the brain, especially the cerebellum. Our studi es show that the mouse is refractory to cerebellar injury following treatme nt with L-CPA and DL-2-bromopropionic acid. The mouse appears to metabolize and excrete L-CPA as its glutathione-derived conjugate(s) more rapidly tha n the rat, thereby limiting the availability of L-CPA to the cerebellum, wh ich may account for the absence of neuronal cell injury.